TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple 
sclerosis

Gregory, A. P.; Dendrou, C. A.; Attfield, K. E.; Haghikia, A.; Xifara, D. K.; Butter, F.; Poschmann, G.; Kaur, G.; Lambert, L.; Leach, O. A.; Promel, S.; Punwani, D.; Felce, J. H.; Davis, S. J.; Gold, R.; Nielsen, F. C.; Siegel, R. M.; Mann, M.; Bell, J. I.; McVean, G.; Fugger, L.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis

MPS-Authors

/persons/resource/persons77831

Butter, F.
Mann, Matthias / Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Max Planck Society;

/persons/resource/persons78356

Mann, M.
Mann, Matthias / Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Gregory, A. P., Dendrou, C. A., Attfield, K. E., Haghikia, A., Xifara, D. K., Butter, F., et al. (2012). TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature, 488(7412), 508-511.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0010-51A1-1

Abstract

There is no abstract available